Intrinsiqq
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc.

BCAX

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$560M
EPS-$3.46
P/E-2.44
P/FCF-3.44
EV/EBITDA-0.50
FCF Yield–
Div. Yield–
Net Debt/FCF2.7x
Bicara Therapeutics Inc. intrinsic value
52-Week Range
$7.93$25.00

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$220M

▼ -102.9% YoY

Op. Margin

–

ROIC

-41.64%

▼ -1.1pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$163M

▼ -43.2% YoY

Op. Cash Flow (TTM)

-$162M

▼ -42.9% YoY

Net Debt

-$441M

Net Cash Position

Cash & Equiv.

$442M

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with BCAX

CompareIntrinsic value
JANXJanux Therapeutics Inc.
$10.08-2.04%40
IRWDIronwood Pharmaceuticals Inc.
$4.70-0.21%63
RIGLRigel Pharmaceuticals, Inc.
$40.09-2.67%86
CAPRCapricor Therapeutics Inc.
$7.59+0.80%10
ABVCABVC BioPharma Inc.
$0.87-1.56%0
GOSSGossamer Bio Inc.
$10.72-4.54%10
CRBPCorbus Pharmaceuticals Holdings, Inc.
$2.06-15.40%10
IBIOiBio, Inc.
$0.80+0.01%10

Held by ETFs

BCAX is in 30 US ETFs. The largest of them, with BCAX's weight in each:

Bicara Therapeutics (BCAX) in two numbers

Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-2.44
Negative: a loss over the last twelve months. Price to free cash flow -3.44.
Financials

Questions about Bicara Therapeutics

Does Bicara Therapeutics (BCAX) pay a dividend?

No. Bicara Therapeutics (BCAX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 3 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in BCAX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BCAX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.